AlphaYou
Overview
Key stats
Fundamentals Sep 12- Open
- $347.66
- 52-wk high
- $603.88
- High
- $362.48
- 52-wk low
- $328.57
- Low
- $345.25
- Prev close
- $353.24
- Mkt cap
- $129.14B
- P/E
- 40.5x
- Volume
- 3.34M
- Fwd P/E
- 29.2x
- Beta
- 1.47
- P/S
- 11.7x
- P/B
- 6.9x
- Profit margin
- +28.4%
- Op margin
- +33.6%
- ROE
- +17.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 17.4% above what analysts expected.
Earnings per share
$2.13 expected
Revenue
No comparable estimate
Company adjusted EPS
From the company's release
The company and the analyst consensus count earnings differently, so the two figures differ. The comparison above uses the analyst basis.
Reports Oct 20, 2026, in 37 days
EPS expected
$2.53 to $2.76
Revenue expected
25 analysts
Last 30 days
Analysts raising estimates
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.51B | $2.87B | $2.77B | $2.89B |
| Cost of what it sold | $842.7M | $961.9M | $940.3M | $931.9M |
| Gross profit | $1.66B | $1.90B | $1.83B | $1.96B |
| What it spent | ||||
| Research and development | $329.4M | $352.9M | $361.9M | $370.6M |
| Sales and admin | $573.3M | $687.1M | $613.3M | $617.9M |
| Total operating expenses | $902.7M | $1.04B | $975.2M | $988.5M |
| What was left | ||||
| Operating profit | $759.7M | $864.3M | $855.3M | $971.9M |
| Profit before tax | $855.2M | $955.6M | $940.4M | $1.05B |
| Tax | $146.0M | $156.1M | $114.4M | $231.4M |
| Net profit | $704.4M | $794.8M | $821.5M | $818.1M |
| EBITDA | $1.02B | $1.18B | $1.14B | $1.17B |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Tone of tracked coverage
Intuitive surgical EVP Mark Brosius sells $17,140 in stock
NeutralSep 12$1000 Invested In Intuitive Surgical 10 Years Ago Would Be Worth This Much Today
BullishSep 11Can High Tide (NASDAQ:HITI) Weather A Tougher Market?
NeutralSep 11Intuitive surgical EVP Brosius sells $24,671 in stock
NeutralSep 10Medtronic Raised its Outlook as Heart Devices Accelerate, But Can the Momentum Last?
NeutralSep 9Chad Phipps Sells 3,000 Shares of Zimmer Biomet (NYSE:ZBH) Stock
NeutralSep 9New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions
BullishSep 8Intuitive study finds da Vinci surgery linked to shorter stays By Investing.com
BullishSep 8
Macro
31 macro signals shaping ISRG right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results